✷ Report Code: A02019 | Pages: 214 | Mar 2022 | 13242 Views | ||
Author(s) : Vikita T , Onkar S | Tables: 152 | Charts: 61 |
|
The global Intravenous Therapy and Vein Access Market size was valued at $22.8 billion in 2020 and is projected to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030. Intravenous (IV) therapy is the process of infusion of liquid substances such as electrolytes, medicines, nutrition, and blood-based products directly into the veins as a therapeutic treatment. IV therapy-based treatment is the fastest way of delivering fluids to different parts of the body. This treatment is used for diseases, including heart attack, stroke, and poisoning. The patient in such cases should receive medication at the earliest, and hence IV medication is prescribed. Therefore, some of the drugs prescribed intravenously include chemotherapy drugs antibiotics, antifungal drugs, pain medications, immunoglobulin medication, and drugs for low blood pressure. IV therapy works fast, is easy to monitor, and prevents side effects to the gastrointestinal system. provides quick immune system response and relief from chronic diseases compared to the oral mode of medication. can be easily monitored and comprises an infusion pump that controls the volume of a substance to be administered in the body.
The overall impact COVID-19 remain positive on the IV therapy market. As IV therapy is used in patients suffering from severe COVID-19-associated Acute Respiratory Distress Syndrome (ARDS). For instance,on11 November 2021, the Lancet Respiratory Medicine Journal published the use of intravenous immunoglobulin therapy for the COVID-19 ARDS is an attractive adjuvant for the management of severe COVID-19-associated ARDS because of its ability to simultaneously modulate multiple immune compartments. Thus, increase in number of patients suffering from COVID-19-associated ARDS has increased the demand for IV therapy and vein access product.
The Intravenous Therapy and Vein Access Market trends include a rise in the incidence of chronic diseases, growth in road accidents, and a surge in trauma cases. In addition, an increase in healthcare expenditure and healthcare insurance are expected to fuel the Intravenous Therapy and Vein Access Market growth during the forecast period. However, the lack of experienced healthcare professionals restricts the market growth. Conversely, the rise in critical care therapies and the increase in the geriatric population are the key factors that provide Intravenous Therapy and Vein Access Market opportunity.
Furthermore, an increase in the number of approved IV drugs that are used for therapy drives the growth of the market. For instance, according to the journal of New England Journal of Medicine (NEJM), the Artesunate injection was approved by Food and Drug Administration (FDA) in June 2020 for the treatment of malaria.
The Intravenous Therapy and Vein Access Market is segmented on the basis of type, medical application, and region. Depending on the type, the market is classified into implantable ports, IV catheters, hypodermic needles, infusion pumps, and others. According to medical application, the market is categorized into volume expanders, medication administration, blood-based products, and nutrition & buffer solutions. As per end-user, the market is fragmented into hospitals, ambulatory surgical centers, and clinics. Region-wise, the Intravenous Therapy and Vein Access Market analysis is done across North America, Europe, Asia-Pacific, and LAMEA.
By Type Segment Review
Intravenous (IV) Therapy and Vein Access Market
By TypeIntravenous Catheters segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
According to type, the Vein Access Industry market is classified into implantable ports, IV catheters, hypodermic needles, infusion pumps, and others. The IV catheters are the fastest growing product segment. The growth of the IV catheter market is fueled by rising in the use of IV catheters during surgical procedures for IV therapies and during the transfer of blood, medicine, and other nutrients to different parts of the body are the key factors driving the growth of the market.
By Medical Application Segment Review
Intravenous (IV) Therapy and Vein Access Market
By Medical ApplicationMedication segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
According to medical applications, the Intravenous Therapy and Vein Access Market market is classified into volume expanders, medication administration, blood-based products, and nutrition & buffer solutions. The medication administration segment held the highest market share, owing to the high usage of IV therapy for transferring medicines for diseases such as diabetes, and cancer.
By End-User Segment Review
As per end-user, the Intravenous Therapy Industry is fragmented into hospitals, ambulatory surgical centers, and clinics. The hospital segment held the highest market share, owing to an increase in the number of surgeries performed compared to ambulatory surgical centers and clinics.
By Region Segment Review
Intravenous (IV) Therapy and Vein Access Market
By RegionNorth America segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Region-wise, the IV therapy & vein access market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the highest Intravenous Therapy and Vein Access Market share in 2020, owing to an increase in the pool of patient population, a rise in prevalence of road accidents, the surge in trauma cases, and an increase in government investments in the development of better healthcare facilities and R&D activities.
The key players operating in the global IV therapy & vein access market include Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.
The other players (the profiles of these players are not covered in the report) in the value chain include Baxter International Inc., iRadimed Corporation, BioScrip, Inc., Grifols, S.A., JW Life Science Co. Ltd., BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd., CVS Health Corporation, and Vifor Pharma Group.
Intravenous (IV) Therapy and Vein Access Market Report Highlights
Aspects | Details |
---|---|
By Type |
|
By Medical Application |
|
By End User |
|
By Region |
|
Key Market Players | Medtronic Inc, Teleflex, B. Braun Melunsung, terumo corporation, AngioDynamics, Inc., Fresenius SE and Co. KGaA., Baxter international plc, Pfizer Inc, Cardinal Health Inc., smiths medical |
Loading Table Of Content...
According to CXOs, utilization of intravenous (IV) therapy and vein access is expected to witness a significant rise across the globe, owing to increase in prevalence of chronic disease such as diabetes, cardiovascular disease, autoimmune disorder and rise in geriatric population. IV therapy is the process of infusion of liquid substances such as electrolytes, medicines, nutrition, and blood-based products directly into the veins as a therapeutic treatment.
The key factors that drive the growth of IV therapy and vein access devices market include rise in incidence & prevalence of chronic diseases, growth in road accidents, and surge in trauma cases. In addition, increase in healthcare expenditure and healthcare insurance is expected to fuel the market growth during the forecast period. However, lack of experienced healthcare professionals restricts the market growth. On the contrary, rise in critical care therapies along with increase in geriatric population are the key factors driving the growth of market.
Furthermore, increase in adoption of IV therapy & vein access products and surge in number of approvals IV drugs used for therapy are the key factors driving the growth of market. For instance, the Artesunate injection was approved by Food and Drug Administration (FDA) on June 2020 for treatment of malaria.
A. North Aerica is the largest regional market for Intravenous (IV) Therapy and Vein Access
A. The top key players operating in the global IV therapy & vein access market include Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc.., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation, and Fresenius SE& CO. KGAA.
A. The Upcoming trends that drive the growth of the IV therapy and vein access devices market include a rise in incidence & prevalence of chronic diseases, growth in road accidents, and surge in trauma cases. In addition, an increase in healthcare expenditure and healthcare insurance is expected to fuel the market growth during the forecast period. However, the lack of experienced healthcare professionals restricts the market growth. Conversely, the rise in critical care therapies and increase in the geriatric population is the key factor driving the growth of market.
A. The Intravenous (IV) Therapy and Vein Access market was valued at $22,808.93 million in 2020
A. The total market value of Intravenous (IV) Therapy and Vein Access Market is $37,537.18 million by 2030
A. No, there is no value chain analysis provided in the Intravenous (IV) Therapy and Vein Access Market Market report
Start reading instantly.
This Report and over 19,981+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers